Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Misswake anti-plaque mouthwash versus chlorhexidine 0.2% for gingivitis and dental plaque
IRCT20240928063187N1Phase 4Completed
- Sponsor
- Shahid Sadoughi University of Medical Sciences
- Start
- Oct 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, triple-blind trial of chlorhexidine in gingivitis (2 arms), sponsored by Shahid Sadoughi University of Medical Sciences. Primary endpoints: O'Leary plaque index, Modified gingival index and 1 more. Started Oct 2024; status: completed.
02
Drugs
chlorhexidine
03
Conditions
gingivitis
Beyond the preview
Go deeper on IRCT20240928063187N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20240928063187N1.